Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy targeting LN and SLE ROCKVILLE, Md., Nov. 16, 2024 /PRNewswire/ — AbelZeta Pharma, Inc.…
Read MoreData also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation…
Read MoreWASHINGTON, Nov. 16, 2024 /PRNewswire/ — Investigators from HSS and collaborating centers identified distinct immune cell patterns in blood that…
Read MoreIN PARTNERSHIP WITH ARTHOUSE/ABBEY ROAD INSTITUTE, SINCE THE PROGRAM’S START IN 2022, ACHIEVES THESE CONSECUTIVE WINS THIS UNIQUE ALLIANCE IS…
Read MoreDual Ceremony Celebrates Completion of VRE Garage PRINCE WILLIAM COUNTY, Va., Nov. 16, 2024 /PRNewswire/ — On Saturday, November 16,…
Read MoreNEW YORK, Nov. 16, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of…
Read MoreWASHINGTON, Nov. 16, 2024 /PRNewswire/ — Physicians are learning how to better support the needs of people with rheumatoid arthritis…
Read MorePLEASANTON, Calif., 16. November 2024 /PRNewswire/ — Anlässlich des diesjährigen Black Friday freut sich DermRays, seinen größten Sale des Jahres…
Read MoreSAN DIEGO, Nov. 16, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers…
Read MoreIn a first-of-its-kind study, tirzepatide also alleviated heart failure symptoms and physical limitations Patients on tirzepatide experienced improved exercise capacity,…
Read More
PRNewswire